Manufacture of basic pharmaceutical products
CHIRON PHARMASYNTH AS
Revenue 2024
NOK 26.1m
Operating profit
NOK −722,000
Equity
NOK 18.9m
Incorporated
2001
Share capital
NOK 1.8m
Varemerker (1)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| The gold standard for forensic analysis | 201301788 | – | Endelig henlagt | 2013-10-05 | – |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.